BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36841132)

  • 1. Inhibiting lncRNA NEAT1 facilitates the sensitization of melanoma cells to cisplatin through modulating the miR-519c-3p-MeCP2 axis.
    Chen Y; Chang Y; Zhou J; Lv L; Ying H
    Pathol Res Pract; 2023 Mar; 243():154364. PubMed ID: 36841132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lncRNA NEAT1 sensitizes medulloblastoma cells to cisplatin through modulating the miR-23a-3p-glutaminase (GLS) axis.
    Ge J; Wang B; Zhao S; Xu J
    Bioengineered; 2022 Mar; 13(3):7670-7682. PubMed ID: 35313796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis.
    Zhu L; Wang F; Fan W; Jin Z; Teng C; Zhang J
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1198-1206. PubMed ID: 34327529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma.
    Zhou WJ; Wang HY; Zhang J; Dai HY; Yao ZX; Zheng Z; Meng-Yan S; Wu K
    Aging (Albany NY); 2020 Nov; 12(22):22759-22775. PubMed ID: 33202380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of LncRNA-NEAT1 alleviates intestinal epithelial cells (IECs) dysfunction in ulcerative colitis by maintaining the homeostasis of the glucose metabolism through the miR-410-3p-LDHA axis.
    Ni S; Liu Y; Zhong J; Shen Y
    Bioengineered; 2022 Apr; 13(4):8961-8971. PubMed ID: 35735114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
    Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
    Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis.
    Chen X; Zhang N
    Cell Biol Int; 2019 Jan; 43(1):44-55. PubMed ID: 30488993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA NEAT1 facilitates melanoma cell proliferation, migration, and invasion via regulating miR-495-3p and E2F3.
    Xia Y; Zhou Y; Han H; Li P; Wei W; Lin N
    J Cell Physiol; 2019 Nov; 234(11):19592-19601. PubMed ID: 31173352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA NEAT1 Knockdown Ameliorates 1-Methyl-4-Phenylpyridine-Induced Cell Injury Through MicroRNA-519a-3p/SP1 Axis in Parkinson Disease.
    Wang S; Wen Q; Xiong B; Zhang L; Yu X; Ouyang X
    World Neurosurg; 2021 Dec; 156():e93-e103. PubMed ID: 34508910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lncRNA NEAT1 induces dysfunction of fibroblast-like synoviocytes in rheumatoid arthritis via miRNA-338-3p-mediated regulation of glutamine metabolism.
    Zhang M; Lu N; Li HJ; Guo XY; Lu L; Guo Y
    J Orthop Surg Res; 2022 Sep; 17(1):401. PubMed ID: 36050752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis.
    Wang W; Ge L; Xu XJ; Yang T; Yuan Y; Ma XL; Zhang XH
    Radiol Oncol; 2019 Nov; 53(4):434-442. PubMed ID: 31747378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.
    Chen Z; Wang Q; Huang L; Xu G; Hu J
    Nutr Cancer; 2023; 75(8):1646-1657. PubMed ID: 37401860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z; Wang Q; Deng MH; Han QL
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.
    Xu J; Xu Y; Ye G; Qiu J
    J Chemother; 2023 Oct; 35(6):527-538. PubMed ID: 36548909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Nuclear Enriched Autosomal Transcript 1 Facilitates Cell Proliferation, Migration Invasion, and Suppresses Apoptosis in Endometrial Cancer by Targeting MicroRNA-202-3p/T Cell Immunoglobulin and Mucin Domain 4 Axis.
    Xu C; Zhai J; Fu Y
    Cancer Biother Radiopharm; 2022 Nov; 37(9):815-823. PubMed ID: 32882142
    [No Abstract]   [Full Text] [Related]  

  • 20. Long noncoding RNA HAGLR sponges miR-338-3p to promote 5-Fu resistance in gastric cancer through targeting the LDHA-glycolysis pathway.
    Hu J; Huang L; Ding Q; Lv J; Chen Z
    Cell Biol Int; 2022 Feb; 46(2):173-184. PubMed ID: 34658120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.